Infections in acute leukemia: an analysis of 240 febrile episodes

Citation
R. Jagarlamudi et al., Infections in acute leukemia: an analysis of 240 febrile episodes, MED ONCOL, 17(2), 2000, pp. 111-116
Citations number
20
Categorie Soggetti
Oncology
Journal title
MEDICAL ONCOLOGY
ISSN journal
13570560 → ACNP
Volume
17
Issue
2
Year of publication
2000
Pages
111 - 116
Database
ISI
SICI code
1357-0560(200005)17:2<111:IIALAA>2.0.ZU;2-E
Abstract
Infections are the major cause of morbidity and mortality in acute leukemia patients. Case records of 91 consecutive patients (AML-48, ALL-40, RAEB-t/ AML-3) treated between January 1997 and July 1999 were studied to determine the type, frequency and severity of infections. Patients' median age was 3 6 y (range 6-66) and male to female ratio was 2.5:1. A total of 240 febrile episodes were recorded; of them, 162 were associated with neutropenia (abs olute neutrophil count, ANC < 500/mm(3)) and 78 were without neutropenia. Among the neutropenic episodes, an infectious etiology could be documented in 52%; the remainder (48%) were defined as isolated febrile episodes. Ches t was the most common site of infection (35.7%) followed by skin, soft tiss ue (13%), GIT (7%) and genitourinary tract (6%) infections in order of decr easing frequency. Microbiologically, gram positive organisms (staphylococcu s aureus, coagulase negative staphylococcus, streptococcus, enterococcus) w ere the most common isolates (52.8%) followed by gram negative organisms (E . coli, klebsiella, pseudomonas) in 42.8% of isolates. Two patients had pul monary tuberculosis and three patients had fungal infections (candida-2, as pergillus-1). Among non-neutropenic patients, infection could be documented in 36%; the r emaining 64% were isolated febrile episodes. Gram negative infections were documented in 50%, gram positive in 30% and fungal infections (candida-4, a spergillus-1, mucormycosis-1) in 20% of them. A combination of third generation cephalosporin and an aminoglycoside were used in 79% of episodes initially; a combination of a newer penicillin and aminoglycoside (4.6%), double betalactums (4.1%), oral antibiotics (9.8%) a nd others were used in the remaining episodes. Fever resolved in 38% of epi sodes using the above combinations; in the remainder second line antibiotic s (mainly vancomycin) and antifungals (amphotericin-B) were added empirical ly or depending on culture and sensitivity. In 52.5% of episodes fever reso lved after addition of second line antibiotics and antifungals. 11 of 91 pa tients died of infectious complications in this study. There is a need for improvised diagnostic tests to detect infections early as well as for new t herapies to overcome antimicrobial resistance.